COVID-19: Vaccines and Therapeutics

Moderna yesterday asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 18 and older who received an initial booster of any authorized or approved COVID-19 vaccine.
Pfizer asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who received an initial booster of any authorized or approved COVID-19 vaccine, based on data from Israel showing the additional booster reduced infections and severe…
The Food and Drug Administration recently authorized extending from six to nine months the shelf life for refrigerated Johnson & Johnson COVID-19 vaccine stored at 2-8 degrees Celsius (about 36-46 degrees Fahrenheit), based on data submitted by the company. 
Timely communications from leaders — bolstered by community vaccination events — are key to ChristianaCare’s COVID-19 vaccination confidence efforts.
As the COVID-19 vaccine continues rolling out to pediatric populations, historically marginalized communities may have questions about the safety of the vaccine.
In a study of 1,364 children aged 5-15, two doses of the Pfizer COVID-19 vaccine reduced the risk of omicron infection by 31% in those under 12 and 59% in older children, the Centers for Disease Control and Prevention reported.
Watch, download and share the videos below to help spread the word to support COVID-19 vaccination efforts.
Puerto Rico governor applauds health care workers as the U.S. territory reaches a COVID-19 vaccine milestone.